Invenia™ ABUS 2.0

Creating a world where breast care has no limits.

Do you want to know more about our new Invenia™ ABUS?

Invenia ABUS

Cancer detection should not be limited by individual risk factor.

Mammography may miss more than 1/3 of breast cancer cases in dense breast tissue. Invenia™ ABUS increase invasive cancer detection sensitivity by 57% when carried out in addition to mammography.

Invenia ABUS

Cancer detection should not be limited by geographical location.

Changing breast care from reactive to proactive to help find small cancers. Wherever women with dense breast may live and make a big impact.

Invenia ABUS

Patient experience should not be limited by lack of knowledge.

Learn about how personalized breast care with Invenia™ ABUS improves breast care patient experience through our education program for physician, technician and patient awareness.

Breast care should not be limited by lack of resources.

ABUS save 44% of radiologist reading time vs traditional ultrasound in a private breast imaging centre.


When breast cancers are found at Stage 1 and 2, 70% of patients have been shown to avoid chemotherapy. Learn how Invenia™ ABUS helps generate an economic advantage related to the patient’s treatment and care.

Invenia ABUS

Learn how ABUS are being implemented in different breast practices

Learn best practices for integrating ABUS into patient care across a variety of practice types in five European Countries



Contact us